Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Introducing UNICORN Signals

Powered By EquityPandit
4.5 Google Ratings

Sun Pharmaceutical Industries Ltd

NSE :SUNPHARMA   BSE :524715  Sector : Pharmaceuticals
Buy, Sell or Hold SUNPHARMA? Ask The Analyst
Check Gift Nifty (SGX Nifty) Live Price to predict the market.

BSE
Mar 28, 00:00

1735.45

4.25 (0.25%)

prev close

1731.20

OPEN PRICE

1733.00

volume

106081

Today's low / high

1705.60 / 1740.60

52 WK low / high

1376.75 / 1960.20

bid price (qty)

0 (0)

offer price (qty)

0 (0)

NSE

prev close

open price

volume

Today's' low / high

52 WK low / high

bid price (qty)

offer price (qty)

28 Mar
1734.70
(0.19%)
27 Mar
1731.45
(-1.56%)
26 Mar
1758.95
(-0.33%)
25 Mar
1764.75
(-1.12%)
24 Mar
1784.80
(0.02%)
21 Mar
1784.50
(1.96%)
20 Mar
1750.25
(1.03%)
19 Mar
1732.35
(-0.88%)
18 Mar
1747.80
(2.55%)
17 Mar
1704.30
(1.24%)
13 Mar
1683.45
(0.39%)
12 Mar
1676.85
(1.30%)
11 Mar
1655.30
(2.72%)
10 Mar
1611.50
(0.14%)
07 Mar
1609.30
(-0.29%)
06 Mar
1614.00
(1.99%)
05 Mar
1582.45
(1.02%)
04 Mar
1566.50
(-1.17%)
03 Mar
1585.10
(-0.51%)
28 Feb
1593.25
(-3.29%)
27 Feb
1647.50
(2.10%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Bullish
Medium Term Investors

Neutral
Long Term Investors

Bearish

Moving Averages

5 DMA
Bearish

1755.13

10 DMA
Bearish

1749.78

20 DMA
Bullish

1683.85

50 DMA
Bullish

1711

100 DMA
Bearish

1758.61

200 DMA
Bearish

1751.28


Intraday Support and Resistance
(Based on Pivot Points) undefined | BSE : 1735.45

Updated On Mar 28, 2025 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1785.11 1763.23 1744.64 - -
R2 1763.23 1749.42 1741.33 1765.14 -
R1 1748.96 1740.89 1738.01 1752.78 1756.1
P 1727.08 1727.08 1727.08 1728.99 1730.65
S1 1712.81 1713.27 1731.39 1716.63 1719.95
S2 1690.93 1704.74 1728.07 1692.84 -
S3 1676.66 1690.93 1724.76 - -

Key Metrics

EPS

13.13

P/E

132.17

P/B

17.65

Dividend Yield

0.78%

Market Cap

4,16,213 Cr.

Face Value

1

Book Value

98.33

ROE

16.13%

EBITDA Growth

4,157.47 Cr.

Debt/Equity

0.08

Shareholding Pattern

  54.48% Total Promoter Holding
12.24% Mutual Fund Holdings
18.05% FIIs
8.92% Non Institution
4.71% Insurance Companies
0% Custodians
1.6% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Sun Pharmaceutical Industries Ltd Quaterly Results


Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
INCOME12630.9 12588.84 13185.3 13645.39 14141.08
PROFIT2583.5 2750.84 2835.62 3040.16 3168.72
EPS10.5 11.1 11.8 12.7 12.1

Sun Pharmaceutical Industries Ltd Quaterly Results


Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
INCOME5150.55 5758.02 4580.81 5214.01 6260.2
PROFIT788.32 867.6 237.82 863.29 1181.05
EPS3 3.6 1 3.6 4.9

Profit & Loss (Figures in Rs. Crores)


Sun Pharmaceutical Industries Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 27825.18 29539.05 32473.22 27097.52 30524.51 33188.24 34995.53 39837.57 45207.11 49595.04
PROFIT 4581.78 5027.37 6932.28 2794.9 3661.85 3960.73 5728.26 6717.12 8604.93 9990.19
EPS 25.79 23.51 32.66 10.7 13.38 17.45 9.52 14.2 35.68 40.21

Sun Pharmaceutical Industries Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 7921.92 8178.89 8366.9 9951.27 11825.95 13904.25 14487.76 16966.04 21379.36 20648.33
PROFIT -1560.14 -1349.86 -266.99 1114.26 1865.28 3017.87 906.04 -1337.5 3356.39 3051.64
EPS 0 0 0 1.27 3.4 13.38 3.51 -0.42 7.05 11.91

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 239.93239.93239.93239.93239.93239.93239.93239.93240.66207.12
Reserves Total 63,426.8255,755.4547,771.2946,222.8545,024.5241,169.1338,074.1836,399.7432,741.1525,382.59
Equity Application Money000000000.6748.38
Total Shareholders Funds63,666.7555,995.3848,011.2246,462.7845,264.4541,409.0638,314.1136,639.6732,982.4825,638.09
Minority Interest3,439.223,320.093,054.893,017.053,860.243,313.543,884.163,790.864,085.252,851.19
Secured Loans 0007.83257.49109.47114.35780.45284.23339.99
Unsecured Loans 3,273.676,885.871,290.33,860.758,057.3910,404.8910,270.929,051.328,212.538,656.12
Total Debt3,273.676,885.871,290.33,868.588,314.8810,514.3610,385.279,831.778,496.768,996.11
Other Liabilities914.46930.141,019.641,098.631,334.281,004.7462.711,341.822,105.512,718.68
Total Liabilities71,294.167,131.4853,376.0554,447.0458,773.8556,241.6653,046.2551,604.1247,67040,204.07
APPLICATION OF FUNDS :
Gross Block 44,283.7143,099.9538,707.3635,578.9935,115.9731,687.0426,948.8124,466.4222,180.4120,406.83
Less: Accumulated Depreciation21,072.3319,034.5116,042.214,026.0112,269.069,850.58,096.166,791.256,308.167,724.36
Net Block23,211.3824,065.4422,665.1621,552.9822,846.9121,836.5418,852.6517,675.1715,872.2512,682.47
Capital Work in Progress5,353.884,973.161,286.81,566.831,220.341,411.152,465.162,801.382,175.452,038.61
Investments 15,025.7714,824.3412,848.599,612.4510,143.117,902.537,142.871,191.881,829.882,716.3
Inventories 9,868.2910,513.058,925.138,997.027,874.997,885.986,880.696,832.816,422.545,667.99
Sundry Debtors 11,249.3711,438.5110,484.599,061.49,421.248,884.27,815.287,202.616,775.665,106.13
Cash and Bank Balance10,520.685,770.295,033.356,445.516,487.557,275.69,929.3815,140.8413,181.6510,998.04
Loans and Advances 3,210.232,767.482,787.592,808.092,973.023,072.692,919.933,546.512,847.645,026.16
Total Current Assets34,848.5730,489.3327,230.6627,312.0226,756.827,118.4727,545.2832,722.7729,227.4926,798.32
Current Liabilities 8,244.467,917.337,076.428,413.455,382.085,288.66,008.655,328.34,536.854,166.36
Provisions 5,769.265,663.099,323.444,761.734,038.393,059.275,242.494,163.033,220.654,352.76
Total Current Liabilities & Provisions14,013.7213,580.4216,399.8613,175.189,420.478,347.8711,251.149,491.337,757.58,519.12
Net Current Assets20,834.8516,908.9110,830.814,136.8417,336.3318,770.616,294.1423,231.4421,469.9918,279.2
Deferred Tax Assets6,077.635,695.314,431.174,712.194,141.53,441.013,095.52,994.373,560.312,245.84
Deferred Tax Liability2,129.042,208.081,613.451,200.261,024.35990.42907.13816.34514.09494.2
Net Deferred Tax3,948.593,487.232,817.723,511.933,117.152,450.592,188.372,178.033,046.221,751.64
Other Assets2,919.632,872.42,926.984,066.014,110.013,870.256,103.064,526.223,276.212,735.85
Total Assets71,294.167,131.4853,376.0554,447.0458,773.8556,241.6653,046.2551,604.1247,67040,204.07
Contingent Liabilities5,172.734,361.773,773.194,714.135,075.525,290.47,430.517,345.514,162.263,538.68
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 239.93239.93239.93239.93239.93239.93239.93239.93240.66207.12
Reserves Total 23,454.4723,508.4324,348.0226,698.5424,156.2922,603.6822,082.6820,772.5421,649.3722,530.77
Equity Application Money000000000.6748.38
Total Shareholders Funds23,694.423,748.3624,587.9526,938.4724,396.2222,843.6122,322.6121,012.4721,890.722,786.27
Secured Loans 0005.416.189.7310.8230.632,939.46281.63
Unsecured Loans 11,226.917,790.825,074.047,352.716,399.76,426.916,873.196,015.982,889.386,529.05
Total Debt11,226.917,790.825,074.047,358.126,405.886,436.646,884.016,046.615,828.846,810.68
Other Liabilities1,722.961,105.451,016.381,342.131,553.68176.19346.091,133.511,825.622,436.88
Total Liabilities36,644.2732,644.6330,678.3735,638.7232,355.7829,456.4429,552.7128,192.5929,545.1632,033.83
APPLICATION OF FUNDS :
Gross Block 18,251.7417,744.6817,194.9815,812.298,244.717,461.346,572.664,988.084,103.75,995.07
Less : Accumulated Depreciation 10,5159,033.017,482.26,143.53,015.972,482.921,928.09949.45529.082,809.8
Net Block 7,736.748,711.679,712.789,668.795,228.744,978.424,644.574,038.633,574.623,185.27
Capital Work in Progress766.11852.91828.641,090.38596.61642.54987.841,100.5767.731,090.59
Investments 12,429.9712,613.2415,548.8715,537.217,361.7217,904.1118,355.2619,333.322,371.6925,876.16
Inventories 3,423.623,989.193,403.743,423.422,633.672,792.622,135.642,308.282,132.152,189.25
Sundry Debtors 8,834.167,125.024,245.166,585.246,168.135,031.475,271.442,714.71,997.811,802.82
Cash and Bank Balance338.39421.28534.96360.98654.78340.77155.27170.28169.11416.46
Loans and Advances 2,316.374,7081,326.852,329.442,089.472,756.961,968.11,154.92943.63947.82
Total Current Assets14,912.5416,243.499,510.7112,699.0811,546.0510,921.829,530.456,348.185,242.75,356.35
Current Liabilities 3,811.447,533.367,524.566,891.414,956.615,713.964,586.353,829.253,541.693,345.03
Provisions 609.08809.52,562.551,204.661,097.942,543.732,652.751,847.431,179.612,066.69
Total Current Liabilities & Provisions4,420.528,342.8610,087.118,096.076,054.558,257.697,239.15,676.684,721.35,411.72
Net Current Assets10,492.027,900.63-576.44,603.015,491.52,664.132,291.35671.5521.4-55.37
Deferred Tax Assets1,826.561,982.841,389.471,969.41,704.221,427.47751.7751.7751.7389.31
Deferred Tax Liability832.04950.451,065.43631.95564.51675.7702.640389.31
Net Deferred Tax994.521,032.39324.041,337.451,139.71751.7751.7749.06751.70
Other Assets4,224.911,533.794,840.443,401.892,537.52,515.542,521.992,299.61,558.021,937.18
Total Assets36,644.2732,644.6330,678.3735,638.7232,355.7829,456.4429,552.7128,192.5929,545.1632,033.83
Contingent Liabilities941.731,087.41,031.723,083.043,439.723,639.135,708.855,636.82,584.822,016.32

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...11,087.89
Depreciation2,556.64
Interest (Net)-784.44
Dividend Received99.14
Prov. and W/O (Net)227.61
P/L in Forex-249.92
Others-77.39
Total Adjustments (PBT and Ext...1,554.4
Operating Profit before Workin...12,642.29
Trade and 0ther Receivables352.89
Inventories598.81
Trade Payables249.72
Total Adjustments (OP before W...1,062.13
Cash Generated from/(used in) ...13,704.42
Direct Taxes Paid-1,569.44
Total Adjustments(Cash Generat...-1,569.44
Cash Flow before Extraordinary...12,134.98
Net Cash from Operating Activi...12,134.98
Purchased of Fixed Assets-2,201.81
Sale of Fixed Assets30.84
Purchase of Investments-29,004.45
Sale of Investments30,094.47
Interest Received613.2
Investment in Group Cos.-86.59
Acquisition of Companies-143.32
Net Cash used in Investing Act...-762.9
Proceed from 0ther Long Term B...4,572.65
Of the Long Tem Borrowings-7,962.58
Of Financial Liabilities-123.1
Dividend Paid-2,900.71
Interest Paid-219.03
Net Cash used in Financing Act...-6,710.16
Net Profit before Tax and Extr...3,449.65
Depreciation1,600.62
Interest (Net)387.65
Prov. and W/O (Net)161.1
P/L in Forex-358.3
Total Adjustments (PBT and Ext...1,768.91
Operating Profit before Workin...5,218.56
Trade and 0ther Receivables-1,477.14
Inventories565.57
Trade Payables-413.63
Total Adjustments (OP before W...-5,169.11
Cash Generated from/(used in) ...49.45
Direct Taxes Paid-341.87
Total Adjustments(Cash Generat...-341.87
Cash Flow before Extraordinary...-292.42
Net Cash from Operating Activi...-292.42
Purchased of Fixed Assets-749.24
Sale of Fixed Assets14.72
Purchase of Investments-2,816.96
Sale of Investments3,039.25
Interest Received267.36
Loans to Subsidiaires-1.53
Acquisition of Companies-16.51
Net Cash used in Investing Act...-265.35
Proceed from 0ther Long Term B...3,453.94
Of the Long Tem Borrowings-10.66
Of Financial Liabilities-5.81
Dividend Paid-2,898.17
Interest Paid-65.35
Net Cash used in Financing Act...473.95

Company Details

Registered Office
AddressSun Pharma Advanced Res.Centre,
Tandalja
CityVadodara
StateGujarat
Pin Code390020
Tel. No.91-265-6615500
Fax. No.91-265-2354897
Emailsecretarial@sunpharma.com
Internethttp://www.sunpharma.com
Registrars
AddressSun Pharma Advanced Res.Centre
CityVadodara
StateGujarat
Pin Code390020
Tel. No.91-265-6615500
Fax. No.91-265-2354897
Emailsecretarial@sunpharma.com
Internethttp://www.sunpharma.com
Management
Name Designation
Dilip S ShanghviChairman & Managing Director
Sudhir V ValiaNon-Exec & Non-Independent Dir
Gautam DoshiNon-Exec. & Independent Dir.
Pawan GoenkaLead Independent Director
Rama BijapurkarIndependent Director
Anoop DeshpandeCompany Sec. & Compli. Officer
Sanjay K AsherIndependent Director
Rolf HoffmannIndependent Director
Aalok ShanghviWhole Time Director